Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Shockwave Medical Inc (NQ: SWAV ) N/A UNCHANGED Last Price Updated: 4:00 PM EDT, May 30, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Shockwave Medical Inc < Previous 1 2 3 4 5 6 7 8 9 10 11 Next > 7 Overlooked Stocks That Belong in Every Portfolio June 03, 2024 Looking beyond the headlines creates an opportunity for investors who have the patience to seek must-own overlooked stocks. Via InvestorPlace Why Sarepta Therapeutics Stock Is Rising Today May 30, 2024 Sarepta Therapeutics, Inc. (NASDAQ: SRPT) stock is trading higher on Thursday after it was announced the company will be added to the S&P MidCap 400. Via Benzinga Topics Stocks Exposures US Equities Johnson & Johnson To Acquire Early-Stage Eczema Treatment Developer Proteologix For $850M May 16, 2024 Johnson & Johnson acquires Proteologix for $850 million, expanding its bispecific antibody portfolio for immune-mediated diseases. Via Benzinga SHOCKWAVE MEDICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Shockwave Medical, Inc. - SWAV May 09, 2024 From Kahn Swick & Foti, LLC Via Business Wire Exploring the Growth Potential of NASDAQ:SWAV as It Nears a Breakout. May 09, 2024 SHOCKWAVE MEDICAL INC (NASDAQ:SWAV), a strong growth stock, setting up for a breakout. Via Chartmill NASDAQ:SWAV: a strong growth stock preparing for the next leg up?. April 17, 2024 Is SHOCKWAVE MEDICAL INC (NASDAQ:SWAV) on the Verge of a Major Breakout as a Strong Growth Stock? Via Chartmill SWAV Stock Earnings: ShockWave Medical Beats EPS, Beats Revenue for Q1 2024 May 06, 2024 SWAV stock results show that ShockWave Medical beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. Via InvestorPlace Shockwave Medical Reports First Quarter 2024 Financial Results May 06, 2024 From Shockwave Medical, Inc. Via GlobeNewswire BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: DecisionPoint Systems, Inc. (NYSE American - DPSI), AdTheorent Holding Company, Inc. (Nasdaq – ADTH), Macatawa Bank Corporation (Nasdaq - MCBC), Shockwave Medical, May 06, 2024 From Brodsky & Smith LLC Via GlobeNewswire BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: DecisionPoint Systems, Inc. (NYSE American - DPSI), AdTheorent Holding Company, Inc. (Nasdaq – ADTH), Macatawa Bank Corporation (Nasdaq - MCBC), Shockwave Medical, May 01, 2024 From Brodsky & Smith LLC Via GlobeNewswire Johnson & Johnson Is a King of Dividend Safety April 29, 2024 The healthcare behemoth has fortified its dividend. Via The Motley Fool Medtech Marvels: 3 Groundbreaking Medical Device Stocks to Watch in 2024 April 25, 2024 The medical device market is growing fast, and top medical device firms can become takeover targets. Here are three medtech stocks to watch. Via InvestorPlace BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Macatawa Bank Corporation (Nasdaq - MCBC), Shockwave Medical, Inc. (Nasdaq – SWAV), Apartment Income REIT Corp. (NYSE - AIRC), Model N, Inc. (NYSE – MODN) April 22, 2024 From Brodsky & Smith LLC Via GlobeNewswire Want to Double Your Tax Refund in 2024? 7 Stocks to Buy Now. April 18, 2024 Investors wondering which tax refund stocks to invest in should consider these names, each of which is a capital compounder. Via InvestorPlace Johnson & Johnson Shows Focus On Strengthening Its Business Upon Its Consumer Health Unit Spinoff April 16, 2024 On Tuesday, Johnson & Johnson (NYSE: JNJ) delivered a rather mixed first quarter report. Adjusted earnings surpassed estimates as sales in its medical devices business surged, while revenue was almost... Via Benzinga BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Macatawa Bank Corporation (Nasdaq - MCBC), Shockwave Medical, Inc. (Nasdaq – SWAV), Apartment Income REIT Corp. (NYSE - AIRC), Model N, Inc. (NYSE – MODN) April 16, 2024 From Brodsky & Smith LLC Via GlobeNewswire BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Shockwave Medical, Inc. (Nasdaq – SWAV), Apartment Income REIT Corp. (NYSE - AIRC), Model N, Inc. (NYSE – MODN), ARCA biopharma, Inc. (Nasdaq - ABIO) April 15, 2024 From Brodsky & Smith LLC Via GlobeNewswire MarketBeat Week in Review – 4/8 - 4/12 April 13, 2024 The latest inflation readings moved stocks lower as investors reconsidered what higher-for-longer interest rates mean for corporate earnings and stock valuation Via MarketBeat Topics Economy Exposures Economy Interest Rates Wall Street Favorites: 3 Biotech Stocks With Strong Buy Ratings for April 2024 April 11, 2024 In a stock picker’s market, here are three biotech stocks analysts believe have a chance to outperform the market in 2024. Via InvestorPlace All-Time High Flyers: 7 Stocks to Buy as the Market Peaks April 11, 2024 These stocks to buy have enjoyed big rallies and the gains look likely to continue in coming months even if the market does peak. Via InvestorPlace 5 Things To Know In Investing This Week - The Shockwave Takeover Issue April 11, 2024 The Shockwave offer that DKI predicted in December happened this week with Johnson & Johnson (NYSE: JNJ)agreeing to pay $335 per share in cash. DKI subscribers celebrated! The PMI came in hot. Don’t... Via Benzinga Wall Street Favorites: 3 Dividend Stocks With Strong Buy Ratings for April 2024 April 10, 2024 These three dividend kings are among the most reliable dividend stocks, and each has at least one strong buy rating. Via InvestorPlace Does Johnson & Johnson's Latest Acquisition Make It a No-Brainer Buy? April 10, 2024 The company is hoping to expand, but is there enough here to attract growth investors? Via The Motley Fool 3 Dividend Growth Stocks With Yields Above 3% That You Can Buy and Hold for the Next Decade April 09, 2024 Income-seeking investors can look forward to steady payout raises from these pharma stocks. Via The Motley Fool SHOCKWAVE MEDICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Shockwave Medical, Inc. - SWAV April 08, 2024 From Kahn Swick & Foti, LLC Via Business Wire Shockwave Reducer Demonstrates Consistent, Positive Results in ‘Real-World’ Study April 08, 2024 Six-Month Results from REDUCER-I Trial Add to Positive Evidence of the Coronary Sinus Reducer to Treat Refractory Angina From Shockwave Medical, Inc. Via GlobeNewswire Johnson & Johnson's $13B Shockwave Medical Deal Accelerates MedTech Strategy, Analyst Says April 08, 2024 Johnson & Johnson acquires Shockwave Medical, bolstering its presence in cardiovascular intervention. The move marks a strategic shift, with around $30 billion invested in MedTech over 18 months. Via Benzinga BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Shockwave Medical, Inc. (Nasdaq – SWAV), Apartment Income REIT Corp. (NYSE - AIRC), Model N, Inc. (NYSE – MODN), ARCA biopharma, Inc. (Nasdaq - ABIO) April 08, 2024 From Brodsky & Smith LLC Via GlobeNewswire Will the Shockwave Medical Deal Be the Jolt JNJ Stock Needs? April 08, 2024 Johnson & Johnson's proposed acquisition of Shockwave Medical may be the jolt that JNJ stock needs to break out of a year-long downtrend Via MarketBeat Disney To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Monday April 08, 2024 Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Via Benzinga < Previous 1 2 3 4 5 6 7 8 9 10 11 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
